BackTable / VI / Podcast / Episode #92

Interventional Oncology in Private Practice (Part 2)

with Dr. Justin Lee

Interventional Radiologist Justin Lee tells us about his approach to treatment of Hepatocellular Carcinoma (HCC), including how this has changed over his years in private practice. This is part two of a two part series.

This podcast is supported by:

TriSalus Life Sciences

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Interventional Oncology in Private Practice (Part 2) with Dr. Justin Lee on the BackTable VI Podcast)

Ep 92 Interventional Oncology in Private Practice (Part 2) with Dr. Justin Lee

00:00 / 01:04

BackTable, LLC (Producer). (2020, October 29). Ep. 92 – Interventional Oncology in Private Practice (Part 2) [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Justin Lee

Dr. Justin Lee is a practicing interventional radiologist at Radiology Associates of Florida in Tampa, FL.

Dr. Christopher Beck

Dr. Chris Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.

Synopsis

In this episode, Dr. Justin Lee joins Dr. Christopher Beck to discuss hepatocellular carcinoma (HCC) and interventional oncology in private practice. Dr. Lee tells us how he frames his HCC patients and works with medical oncologists for treatment plans and procedures.

We talk about the importance of IR bringing cases to the tumor board, the evolution of cases involving ablation, and why Dr. Lee started moving towards radioembolization (Y90). We review how to approach HCC cases while working with medical oncologists.

We examine the differences between using resin and glass for radioembolization and when they should be used. Dr. Lee shares why IR should start looking into arterial drug delivery for immunotherapies.

Resources

NEJM: Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
https://www.nejm.org/doi/10.1056/NEJMoa1915745
This paper, mentioned by Dr. Lee, discusses the third phase of an HCC trial.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

Multidisciplinary Cancer Care: Lynn's Chemoembolization and More with Lynn Lazzaro on the BackTable VI Podcast)

Surviving Cancer: A Patient's Radioembolization Journey with Suzanne Martin on the BackTable VI Podcast)

Mastering Microwave Ablation in HCC Treatment with Dr. Zach Berman on the BackTable VI Podcast)

Immunotherapy in HCC: Evolving Treatment Paradigms with Dr. Tyler Sandow, Dr. Edward Kim and Dr. Terence Gade on the BackTable VI Podcast)

How I Perform a Port Removal with Dr. Christopher Beck on the BackTable VI Podcast)

Iliofemoral Stenting: Decision-Making & Best Practices Explored with Dr. Kush Desai and Dr. Steven Abramowitz on the BackTable VI Podcast)

Articles

Topics

Hepatocellular Carcinoma Condition Overview

Learn about Interventional Oncology on BackTable VI

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.